Atlas Trials

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00685841 · COMPLETED

Trial details

NCT number
NCT00685841
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD
Start date
2002-02-01
Primary completion
2003-06-01
Enrollment
717

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.